Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monitoring SARS-CoV-2 variants with complementary surveillance systems: risk evaluation of the Omicron JN.1 variant in France, August 2023 to January 2024.
Traore A, Charniga K, Grellet S, Terpant G, Da Cruz H, Lamy A, Thomas N, Gbaguidi G, Mercier A, Prudhomme J, Visseaux B, Vieillefond V, Haim-Boukobza S, Giannoli JM; RELAB Study Group; Laboratory group; Castro-Alvarez J, Kouamen AC, Rameix-Welti MA, Beirrera-Ibraim S, Destras G, Josset L, Cauchemez S, Lina B, Coignard B, Schaeffer J, Enouf V, Bal A; Members of the Laboratory Group; Members of the RELAB Study Group. Traore A, et al. Euro Surveill. 2025 Jan;30(1):2400293. doi: 10.2807/1560-7917.ES.2025.30.1.2400293. Euro Surveill. 2025. PMID: 39790077 Free PMC article.
HIV-1 reservoir landscape of post-treatment control.
Charre C, Merad Y, Avettand-Fenoel V. Charre C, et al. Among authors: avettand fenoel v. Curr Opin HIV AIDS. 2025 Jan 1;20(1):99-108. doi: 10.1097/COH.0000000000000891. Epub 2024 Oct 21. Curr Opin HIV AIDS. 2025. PMID: 39484860 Review.
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study.
Fourati S, Reslan A, Bourret J, Casalegno JS, Rahou Y, Chollet L, Pillet S, Tremeaux P, Dossou NC, Gault E, Salmona M, Imbert-Marcille BM, Mirand A, Larrat S, Moisan A, Marot S, Schnuriger A, Veyrenche N, Engelmann I, Handala L, Henry A, Stephan V, Brichler S, Avettand-Fenoel V, Zemali N, Lefeuvre C, Pronier C, Deroche L, Jaffar-Bandjee MC, Mouna L, Francois C, Regueme A, Hartard C, Rogez S, Gallais F, Ly A, Rodriguez C, Dos Santos G, Simon-Loriere E, Schwartz O, Buchrieser J, Pawlotsky JM, Lemoine F, Audureau E, Rameix-Welti MA; POLYRES investigators. Fourati S, et al. Among authors: avettand fenoel v. Lancet Infect Dis. 2024 Oct 14:S1473-3099(24)00570-X. doi: 10.1016/S1473-3099(24)00570-X. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39419046
Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data.
Vemparala B, Madelain V, Passaes C, Millet A, Avettand-Fenoel V, Djidjou-Demasse R, Dereuddre-Bosquet N, Le Grand R, Rouzioux C, Vaslin B, Sáez-Cirión A, Guedj J, Dixit NM. Vemparala B, et al. Among authors: avettand fenoel v. PLoS Comput Biol. 2024 Sep 10;20(9):e1012434. doi: 10.1371/journal.pcbi.1012434. eCollection 2024 Sep. PLoS Comput Biol. 2024. PMID: 39255323 Free PMC article.
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells.
Sáez-Cirión A, Mamez AC, Avettand-Fenoel V, Nabergoj M, Passaes C, Thoueille P, Decosterd L, Hentzien M, Perdomo-Celis F, Salgado M, Nijhuis M, Mélard A, Gardiennet E, Lorin V, Monceaux V, Chapel A, Gourvès M, Lechartier M, Mouquet H, Wensing A, Martinez-Picado J, Yerly S, Rougemont M, Calmy A. Sáez-Cirión A, et al. Among authors: avettand fenoel v. Nat Med. 2024 Dec;30(12):3544-3554. doi: 10.1038/s41591-024-03277-z. Epub 2024 Sep 2. Nat Med. 2024. PMID: 39222660 Free PMC article.
Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration.
Pantazis N, Sabin CA, Grabar S, Van der Valk M, Jarrin I, van Sighem A, Meyer L, Carlander C, Gill J, Volny Anne A, Spire B, Tariq S, Burns F, Costagliola D, Ruiz-Burga E, Touloumi G, Porter K; CASCADE Collaboration. Pantazis N, et al. Lancet HIV. 2024 Oct;11(10):e660-e669. doi: 10.1016/S2352-3018(24)00183-8. Epub 2024 Aug 23. Lancet HIV. 2024. PMID: 39186940
Unexpected discovery of Trypanosoma brucei gambiense on CSF in a western country: About a case.
Francois LA, Bret L, Wong So J, Gubavu C, Touafek F, Vinsonneau M, Kochbati K, Avettand-Fenoel V, Guillaume C, Carbonnelle E, Guinard J, Mchantaf G. Francois LA, et al. Among authors: avettand fenoel v. Travel Med Infect Dis. 2024 Jul-Aug;60:102741. doi: 10.1016/j.tmaid.2024.102741. Epub 2024 Jul 14. Travel Med Infect Dis. 2024. PMID: 39004328 Free article. No abstract available.
Fully injectable antiretroviral multitherapy to overcome decades of virological failure in three women with hiv-1 and non-adherent to oral drugs.
Hocqueloux L, Mchantaf G, Bafong-Ketchemen S, Bois J, Guinard J, Prazuck T, Sève A, Avettand-Fènoël V. Hocqueloux L, et al. Among authors: avettand fenoel v. Int J Antimicrob Agents. 2024 Sep;64(3):107254. doi: 10.1016/j.ijantimicag.2024.107254. Epub 2024 Jun 24. Int J Antimicrob Agents. 2024. PMID: 38925226 No abstract available.
DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirine.
Soulie C, Balde A, Fofana D, Charpentier C, Bonnafous P, Sourice J, De Monte A, Avettand-Fenoel V, Le Guillou-Guillemette H, Bocket L, Raymond S, Marque Juillet S, Trabaud MA, Montes B, Maillard A, Hartard C, Alessandri-Gradt E, Brochot E, Signori-Schmuck A, Assoumou L, Marcelin AG. Soulie C, et al. Among authors: avettand fenoel v. J Antimicrob Chemother. 2024 Aug 1;79(8):1974-1984. doi: 10.1093/jac/dkae194. J Antimicrob Chemother. 2024. PMID: 38884154
190 results